Neurological Sciences,
Год журнала:
2020,
Номер
41(6), С. 1437 - 1449
Опубликована: Фев. 12, 2020
Abstract
Background
Many
patients
with
brain
tumours
exhibit
mild
to
severe
(neuro)cognitive
impairments
at
some
point
during
the
course
of
disease.
Social
cognition,
as
an
instance
higher-order
cognitive
functioning,
specifically
enables
initiation
and
maintenance
appropriate
social
interactions.
For
individuals
being
confronted
diagnosis
a
tumour,
impairment
function
represents
additional
burden,
since
those
deeply
depend
on
support
empathy
provided
by
family,
friends
caregivers.
Methods
The
present
study
explores
scientific
landscape
(socio)cognitive
functioning
in
tumour
conducting
comprehensive
bibliometric
analysis
using
VOSviewer.
Web
Science
Core
Collection
database
was
examined
identify
relevant
documents
published
between
1945
2019.
Results
A
total
664
English
titles
functions
retrieved.
Automated
textual
revealed
that
data
available
so
far
focus
three
major
topics
patients:
general
paediatric
cases,
well
psychological
factors
their
influence
quality
life.
research
has
gradually
moved
from
clinical
studies
one
outcome
measures
investigations
interactions
constructs
such
anxiety,
depression
or
fatigue.
Medical,
neurological
neuropsychological
journals,
particular
neuro-oncological
journals
most
articles
authored
relatively
small
network
interconnected
researchers
field.
Conclusion
highlights
necessity
more
cognition
patients.
Abstract
Objective
Cancer‐related
cognitive
impairment
has
severe
implications
for
the
quality
of
life
and
societal
participation
cervical
cancer
survivors
(CCS).
However,
there
is
no
research
on
association
between
subjective
objective
(CI)
in
cancer.
This
cross‐sectional
study
aimed
to
examine
frequency
severity
CI
CCS
reporting
significant
explore
discrepancy
CI.
Methods
Sixty‐five
CI,
defined
as
1.5
SD
below
normative
mean,
underwent
neuropsychological
(NP)
assessment
covering
attention,
verbal
memory,
processing
speed,
fluency,
executive
functions.
were
compared
healthy
age‐matched
controls
(
n
=
74).
A
versus
score
was
calculated
based
standardized
scores
within
each
group.
Results
The
group
performed
significantly
poorer
across
all
NP
tests
(all
p
‐values
<0.001)
81.5%
had
cut‐off
by
International
Cognition
Cancer
Task
Force.
published
data,
most
clinically
normal
range.
Processing
speed
memory
affected
domains.
By
calculating
a
score,
both
groups
average
displayed
quite
accurate
concordance
functioning.
Conclusion
Although
evident
CCS,
our
results
confirm
that
represent
different
constructs
highlight
limitations
data.
Differentiating
important
when
tailoring
effective
interventions
survivorship
care
CCS.
Neuro-Oncology Practice,
Год журнала:
2021,
Номер
9(1), С. 50 - 58
Опубликована: Сен. 7, 2021
Abstract
Background
Knowledge
regarding
cognitive
problems
in
metastatic
non-small
cell
lung
cancer
(mNSCLC)
is
limited.
Such
may
include
both
patient-reported
concerns
and
demonstrable
impairment.
Greater
understanding
of
these
outcomes
needed
to
inform
rehabilitation
strategies
for
difficulties.
We
aimed
identify
the
frequency
associated
factors
patients
with
mNSCLC.
Methods
In
this
cross-sectional
study,
adults
mNSCLC
completed
validated
neuropsychological
tests
self-report
questionnaires
measuring
concerns,
neurobehavioral
depression,
demoralization,
illness
intrusiveness,
self-esteem,
physical
symptoms.
Cognitive
impairment
(performance
based)
was
defined
according
International
Cancer
Cognition
Task
Force
criteria.
Clinically
significant
were
by
a
score
≥1.5
SD
below
normative
mean
on
Functional
Assessment
Therapy-Cognitive
Function
Perceived
Impairment
(FACT-Cog
PCI).
Univariate
multivariate
logistic
regression
analyses
performed
factors.
Results
Of
238
approached,
77
participated
(median
age:
62
years;
range:
37-82).
Brain
metastases
present
41
(53%),
23
(29%)
received
cranial
irradiation.
31
(40%)
20
(26%),
respectively.
co-occurred
10
(13%),
but
their
severity
unrelated.
irradiation
(odds
ratio
[OR]
=
2.89;
P
.04),
whereas
greater
intrusiveness
(OR
1.04;
.03)
lower
self-esteem
0.86;
.03).
Conclusions
are
common
not
necessarily
related,
risk
differ.
The
association
can
therapeutic
interventions
population.
Epilepsia,
Год журнала:
2023,
Номер
64(7), С. 1887 - 1899
Опубликована: Апрель 21, 2023
Many
people
with
epilepsy
report
subjective
cognitive
impairment
(SCI),
i.e.,
problems
memory,
attention,
or
executive
functions,
reducing
quality
of
life.
Nevertheless,
overlap
objective
(OCI)
is
often
weak.
One
reason
may
be
a
domain-specific
mismatch
between
reports
and
tests.
We
aimed
to
evaluate
relations
SCI
OCI
corresponding
domains
assess
whether
these
differ
persons
who
over-
underestimate
their
performance.In
this
prospective,
cross-sectional
sample
104
adult
inpatients
epilepsy,
we
performed
multiple
regression
analyses
predicting
in
the
functions.
tested
relationships
measures
psychomotor
speed,
short-term
verbal
learning,
delayed
recall,
word
fluency
while
controlling
for
age,
sex,
seizure
frequency,
structural
lesions,
mono-
versus
polytherapy
adverse
events
antiseizure
medication
(ASM),
depressive
anxiety
symptoms,
level
education,
employment
status.
Furthermore,
differed
realistic
raters
underestimators.We
found
attention
functions
full
sample,
explaining
small
proportion
variance
(general
dominance
index
=
.03
.004),
whereas
ASM
psychological
variables
were
more
important
predictors.
When
dividing
according
concordance
OCI,
high
frequencies
both
(23%-46%)
underestimation
(31%-35%)
depending
on
domain.
The
explanatory
power
was
stronger
within
subgroups
compared
suggesting
nonlinear
different
underlying
mechanisms
raters,
underestimators,
overestimators.Domain-specific
are
related,
should
assessed
standardized
instruments.
These
underestimators
as
well
raters.
Based
self-ratings
measures,
tailored
counseling
treatment
offered.
Journal of Clinical Oncology,
Год журнала:
2020,
Номер
38(12), С. 1312 - 1321
Опубликована: Фев. 21, 2020
Using
a
candidate
gene
approach,
we
tested
the
hypothesis
that
individual
single
nucleotide
polymorphisms
(SNPs)
and
gene-level
variants
are
associated
with
cognitive
impairment
in
patients
hematologic
malignancies
treated
blood
or
marrow
transplantation
(BMT)
inclusion
of
these
SNPs
improves
risk
prediction
beyond
offered
by
clinical
demographic
characteristics.In
discovery
cohort,
BMT
recipients
underwent
standardized
battery
neuropsychological
tests
pre-BMT
at
6
months,
1
year,
2
years,
3
years
post-BMT.
Associations
between
68
genes
were
assessed
using
generalized
estimating
equation
models.
Elastic-Net
regression
was
used
to
build
Base
(sociodemographic),
Clinical,
Combined
(Base
plus
Clinical
genetic)
models
post-BMT
impairment.
An
independent
nonoverlapping
cohort
from
Survivor
Study
self-report
learning/memory
problems
(as
identified
their
health
care
provider)
for
model
replication.The
included
277
participants
(58.5%
males;
68.6%
non-Hispanic
whites;
46.6%
allogeneic
recipients).
Adjusting
type,
age
BMT,
sex,
race/ethnicity,
reserve,
blood-brain
barrier,
telomere
homeostasis,
DNA
repair
significantly
Compared
Model,
Model
had
higher
predictive
power
both
(mean
area
under
receiver
operating
characteristic
curve
[AUC],
0.89;
95%
CI,
0.85
0.93
v
0.77;
0.71
0.83;
P
=
1.24
×
10-9)
replication
(AUC,
0.71;
0.66
0.76
0.63;
0.57
0.68;
.004).Inclusion
genetic
enhanced
demographic/clinical
characteristics
represents
step
toward
personalized
approach
managing
high
after
BMT.
Psycho-Oncology,
Год журнала:
2022,
Номер
31(8), С. 1275 - 1285
Опубликована: Июнь 21, 2022
Cancer-related
cognitive
impairments
(CRCI)
are
common
after
treatment
and
can
have
important
impacts
on
the
lives
of
adolescent
young
adult
(AYA)
cancer
survivors-those
survivors
diagnosed
between
ages
15
39.
However,
most
research
focuses
under
age
or
over
39
so
we
know
relatively
little
about
CRCI
among
AYA
non-central
nervous
system
(CNS)
cancers.
Here
review
non-CNS
cancers
to
determine
prevalence,
associated
factors,
impact
survivors'
as
well
implications
for
future
research.In
November
2021
performed
a
systematic
search
literature
in
MEDLINE,
Web
Science,
PsycInfo,
CINAHL,
EMBASE,
Cochrane
Central
Register
Controlled
Trials
identify
peer-reviewed
English
language
articles
describing
original
with
at
least
one
outcome
conducted
AYAs.
We
screened
6003
21
met
eligibility
criteria.
Guided
by
PRISMA-ScR
Checklist,
extracted
study
information
meet
objectives.Most
studies
employed
cross-sectional
surveys
interviews,
though
some
longitudinal
methods,
neurocognitive
assessments,
brain
imaging.
From
subset
that
reported
prevalence
calculated
weighted
mean
25.75%
median
27.8%.
The
factors
included
female
gender,
higher
dose
chemotherapy,
comorbidities.
impacted
through
impaired
role
functioning,
financial
toxicity,
unmet
needs.CRCI
is
highly
prevalent
AYAs
quality
life
functioning.
This
suggests
need
further
longitudinal,
imaging,
mixed
methods
provision
resources
help
achieve
better
educational
occupational
attainment
during
what
potentially
decades-long
survivorship
period.
although
interventions
might
improve
cognition
identified
only
pilot
study.
Digital
may
be
practical
effective
option
this
group,
but
they
yet
adequately
investigated.
Objective
Millions
of
cancer
survivors
are
at
risk
for
cancer-related
cognitive
impairment
(CRCI),
yet
accurate
and
accessible
assessments
functioning
remain
limited.
Ecological
mobile
testing
(EMCT)
could
offer
a
solution.
This
paper
presents
the
protocol
study
that
aims
to
(1)
establish
reliability
validity
EMCT
assess
CRCI
in
breast
survivors,
(2)
prospectively
evaluate
within-person
processes
(and
interactions)
among
context,
mood,
behavior
explain
variability,
everyday
functioning,
quality
life
survivors.
Methods
Participants
will
include
(>21
years
old)
who
within
5
completing
chemotherapy
treatment.
complete
two
virtual
visits
(baseline,
follow-up)
2
months
apart
self-reported
symptoms
performance,
sociodemographic
characteristics,
clinical
history,
life.
Between
visits,
be
used
sample
every
other
day
(28
times
total).
We
use
linear
mixed-effect
regressions
single-level
multiple
regression
models
analyze
data.
Results
anticipate
minimum
124
enrolling
data
collection.
Study
results
published
peer-reviewed
scientific
journals.
Conclusions
Our
findings
have
broad
implications
assessing
an
ecologically
valid
person-centered
way
using
EMCT.
aim
provide
this
aid
researchers
would
like
apply
approach
their
studies.
Frontiers in Medicine,
Год журнала:
2023,
Номер
10
Опубликована: Авг. 29, 2023
Cancer
related
cognitive
impairment
(CRCI)
is
commonly
associated
with
cancer
and
its
treatments,
yet
the
present
binary
diagnostic
approach
fails
to
capture
full
spectrum
of
this
syndrome.
Cognitive
function
highly
complex
exists
on
a
continuum
that
poorly
characterized
by
dichotomous
categories.
Advanced
statistical
methodologies
applied
symptom
assessments
have
demonstrated
there
are
multiple
subclasses
CRCI.
However,
studies
suggest
relying
alone
may
fail
account
for
significant
differences
in
neural
mechanisms
underlie
specific
phenotype.
Treatment
plans
address
physiologic
involved
an
individual
patient’s
condition
heart
precision
medicine.
In
narrative
review,
we
discuss
how
biotyping,
medicine
framework
being
utilized
other
mental
disorders,
could
be
Specifically,
neuroimaging
can
used
determine
biotypes
CRCI,
which
allow
increased
prediction
diagnosis
CRCI
via
biologic
mechanistic
data.
Biotypes
also
provide
more
precise
clinical
endpoints
intervention
trials.
Biotyping
made
feasible
proxy
imaging
technologies
or
liquid
biomarkers.
Large
cross-sectional
phenotyping
needed
addition
evaluation
longitudinal
trajectories,
data
sharing/pooling
currently
available
digital
infrastructures.
Abstract
Objective
There
is
a
dearth
of
literature
describing
young
adult
(YA)
cancer
survivors'
experiences
with
cancer‐related
cognitive
impairment
(CRCI).
We
aimed
to
elucidate
CRCI
among
YA
survivors
and
identify
potentially
modifiable
risk
factors.
Methods
conducted
individual
qualitative
interviews
aged
18–30
years
at
study
enrollment
used
applied
thematic
analysis
themes
across
three
topics
(i.e.,
affected
abilities,
protective
factors
influencing
the
impact
CRCI,
strategies
for
coping
CRCI).
Results
(
N
=
20)
were,
on
average,
23
old
diagnosis
26
when
interviewed.
Diverse
types
treatments
were
represented;
most
participants
(85%)
had
completed
treatment.
Participants
described
topics:
(1)
abilities
concentration
attention,
prospective
memory,
long‐term
memory),
(2)
Risk
fatigue,
sleep
problems,
mood,
stress/distractions,
social
isolation)
support),
(3)
strategies,
including
practical
that
helped
build
self‐efficacy
(e.g.,
writing
things
down,
reducing
distractions),
beneficial
emotion‐focused
focus
health,
faith/religion),
mixed
effects
apps/games,
medications/supplements,
yoga),
“powering
through”
exacerbated
stress.
Conclusions
experience
enduring
difficulties
after
Specific
concerns
highlight
importance
attention
executive
functioning
impairments,
memory
recall,
sensitivity
distractions.
Future
work
needed
improve
assessment
treatment
survivors.